The oncogenic role of BCL9L in lung cancers is also supported by the comparison of ∆Np63-regulated enhancers associated genes in AT2 cells and in LUAD derived from tumours of KrasG12D/+ mice, showing that BCL9L is included in the common gene set (Fig. 8d and Supplementary dataset 6). The gene discussed is BCL9L; the disease is neoplasm.